Pure Global

ILLUMINA COLOMBIA S.A.S. - Authorized Company ProfileILLUMINA COLOMBIA S.A.S.

Explore comprehensive authorized company profile for ILLUMINA COLOMBIA S.A.S. through Pure Global AI's free Colombia medical device database. This company manufactures 219 medical devices registered with INVIMA across 2 risk classes. Their registration history spans from Jul 18, 2029 to Oct 17, 2033.

This page provides detailed insights including recent registrations, risk class distribution (I: 204, Unspecified: 15), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
219 Devices
2 Risk Classes
ILLUMINA COLOMBIA S.A.S.
ILLUMINA COLOMBIA S.A.S.
Authorized Company
219
Total Devices
2
Risk Classes
2029
Earliest
2033
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

TSO 500 DNA/RNA + 3 NEXTSEQ HO FC

TSO 500 DNA/RNA + 3 NEXTSEQ HO FC

a92656c0f44a5372e1b3d8a6f6eba119

Oct 17, 2033

VIRAL SURVEILLANCE PANEL WITH ILLUMINA RNA PREP WITH ENRICHMENT INDEXES SET A

VIRAL SURVEILLANCE PANEL WITH ILLUMINA RNA PREP WITH ENRICHMENT INDEXES SET A

04fa96e0e348d8dc17911003156fa23f

I
Feb 14, 2033

HRD TRUSIGHT ONCOLOGY 500 HRD KIT

HRD TRUSIGHT ONCOLOGY 500 HRD KIT

69f63e5412c137fa81a4ce0942513e23

I
Feb 14, 2033

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET C (96 INDEXES, 96SAMPLES)

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET C (96 INDEXES, 96SAMPLES)

ab2e0da5f4fd1caed76ec7b5134388e9

I
Feb 14, 2033

ILLUMINA® STRANDED MRNA PREP, LIGATION

ILLUMINA® STRANDED MRNA PREP, LIGATION

7fa6b7c871b237e4baada863d6fa23e5

I
Feb 14, 2033

VIRAL SURVEILLANCE PANEL

VIRAL SURVEILLANCE PANEL

e6479c93f27aaecc8f7cc7ac41b9bbc1

I
Feb 14, 2033

NEXTSEQ™ 1000/2000 INDEX PRIMER KIT

NEXTSEQ™ 1000/2000 INDEX PRIMER KIT

e4fbba4cb9969e5fa536853efb081165

I
Feb 14, 2033

NEXTSEQ™ 2000 P3 REAGENTS

NEXTSEQ™ 2000 P3 REAGENTS

4a74fd6c03ff3711204d77d441198375

I
Feb 14, 2033

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET A (96 INDEXES, 96SAMPLES)

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET A (96 INDEXES, 96SAMPLES)

d239c12f5bb8cea96e2a7d23f98e50c8

I
Feb 14, 2033

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET B (96 INDEXES, 96SAMPLES)

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET B (96 INDEXES, 96SAMPLES)

8603ba5fbf51c859709bbb8dc87c471a

I
Feb 14, 2033

INFINIUM CYTOSNP-850K V1.3 BEADCHIP KIT

INFINIUM CYTOSNP-850K V1.3 BEADCHIP KIT

7004f9c76b8c21e70b431905015f8271

I
Feb 14, 2033

ILLUMINA® DNA PREP, (M) TAGMENTATION (24 SAMPLES, IPB)

ILLUMINA® DNA PREP, (M) TAGMENTATION (24 SAMPLES, IPB)

6e01d08816607a8098d0294ec7fa350a

I
Feb 14, 2033

TRUSEQ NANO DNA HIGH THROUGHPUT LIBRARY PREP KIT (96 SAMPLES) 

TRUSEQ NANO DNA HIGH THROUGHPUT LIBRARY PREP KIT (96 SAMPLES) 

25fd2e9b0340440354f0bc3518c449b3

I
Feb 14, 2033

TRUSEQ NANO DNA LOW THROUGHPUT LIBRARY PREP KIT (24 SAMPLES)

TRUSEQ NANO DNA LOW THROUGHPUT LIBRARY PREP KIT (24 SAMPLES)

0c5b2c62900a9ef07cf2aa8c4ec6b1c5

I
Feb 14, 2033

PAN-CORONAVIRUS PANEL

PAN-CORONAVIRUS PANEL

55267bd7469937ea20cac3d9830068ad

I
Feb 14, 2033

INFINIUM METHYLATION EPIC BEADCHIP KIT

INFINIUM METHYLATION EPIC BEADCHIP KIT

444f78c30193cfe31b035c32dd97ccb7

Feb 14, 2033

NEXTSEQ™ 1000/2000 READ PRIMER KIT

NEXTSEQ™ 1000/2000 READ PRIMER KIT

21bb7feb5c85fb92f0f8c81af55fcef6

I
Feb 14, 2033

NEXTSEQ™ 1000/2000 P2 REAGENTS

NEXTSEQ™ 1000/2000 P2 REAGENTS

3e2d457a8bd3d8b6af7028b4d62dc9a9

I
Feb 14, 2033

HISEQ INSTALL ACCESORIES BOX

HISEQ INSTALL ACCESORIES BOX

94f7da31cb911de8b693a8dd07430183

I
Feb 14, 2033

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET D (96 INDEXES, 96SAMPLES)

RESPIRATORY PATHOGEN ID/AMR ENRICHMENT KIT SET D (96 INDEXES, 96SAMPLES)

701c2880041d21d4456e72415f52f952

I
Feb 14, 2033
Risk Class Distribution
Devices by risk class
I
204
93.2% of total
Unspecified
15
6.8% of total